BISAP Score: Purpose and Calculation
The BISAP (Bedside Index for Severity in Acute Pancreatitis) score is a simplified 5-point prognostic tool that can be calculated within the first 24 hours of presentation to identify patients at increased risk of mortality and severe disease, with a score ≥3 indicating significantly elevated risk and a score ≥2 serving as a clinically meaningful cutoff for severe acute pancreatitis and organ failure. 1
Calculation Method
Score 1 point for each of the following criteria present within 24 hours:
- Blood urea nitrogen (BUN) > 25 mg/dL (>8.9 mmol/L) 1
- Impaired mental status (disorientation, lethargy, coma) 1
- Systemic inflammatory response syndrome (SIRS) present 1
- Age > 60 years 1
- Pleural effusion detected on imaging 1
Total possible score: 0-5 points 1
Clinical Purpose and Performance
Primary Outcome: Mortality Prediction
- BISAP ≥3 predicts mortality with 56% sensitivity and 91% specificity, with positive likelihood ratio of 5.65 2
- The score demonstrates similar accuracy to APACHE-II for predicting death (AUC 0.82-0.86 vs 0.87) but is far simpler to calculate 3, 4, 5
- Critical advantage: BISAP identifies patients at increased risk of mortality BEFORE the onset of organ failure, unlike traditional scoring systems 1
Secondary Outcomes: Severity and Organ Failure
- BISAP ≥2 is the statistically significant cutoff for severe acute pancreatitis, organ failure, and mortality 1, 4
- For organ failure prediction, BISAP achieves AUC of 0.93, performing as well as APACHE-II (0.95) and superior to Ranson criteria (0.84) 4
- BISAP ≥3 increases risk of organ failure 7.4-fold, persistent organ failure 12.7-fold, and pancreatic necrosis 3.8-fold 5
Key Advantages Over Traditional Scoring Systems
Timing Advantage
- BISAP can be calculated within the first 24 hours of admission, while Ranson and APACHE-II require 48 hours for full assessment 1
- This enables immediate risk stratification on admission rather than waiting 2 days 1
Simplicity Advantage
- All five BISAP components are clinically relevant and routinely available 3
- No complex physiological calculations required, unlike APACHE-II's 12 parameters 6
- Can be calculated at bedside without specialized software 1
Comparative Performance
- BISAP outperforms Ranson criteria, CT severity index, CRP, hematocrit, and BMI for predicting severity and organ failure 1, 4
- BISAP shows higher specificity (91%) compared to Ranson (68-77.5%) and APACHE-II, though with lower sensitivity 2
- The World Journal of Emergency Surgery guidelines note that BISAP was derived from 17,992 patients and validated on 18,256 patients in the USA 1
Clinical Application Algorithm
Score 0-1: Low Risk
- Mortality risk minimal 5
- Standard ward-level care typically appropriate 5
- Continue monitoring for clinical deterioration 5
Score 2: Intermediate Risk
- This is the cutoff for severe acute pancreatitis and organ failure 1, 4
- Consider ICU-level monitoring or step-down unit 7
- Aggressive fluid resuscitation and close surveillance required 7
Score ≥3: High Risk
- Significantly elevated mortality risk 1, 2, 5
- ICU admission strongly recommended 7
- Monitor for development of organ failure, which defines severe disease 7
- Serial procalcitonin measurements to detect infected necrosis 7
- Contrast-enhanced CT between days 3-10 to assess for necrosis 7
Important Clinical Caveats
Limitations to Recognize
- BISAP has suboptimal sensitivity (51-56%) for both mortality and severe disease, meaning it will miss some high-risk patients 2
- The positive predictive value varies by population and disease prevalence 1
- Do NOT use BISAP score alone—complement with clinical judgment, CRP at 48-72 hours, and CT severity index 7
Common Pitfalls to Avoid
- Do NOT delay aggressive management waiting for BISAP calculation—initiate fluid resuscitation immediately based on clinical presentation 7
- Do NOT administer prophylactic antibiotics based on high BISAP score alone—antibiotics are only indicated for documented infected necrosis, not for risk stratification 1, 7
- Do NOT obtain CT scan in first 72 hours based solely on BISAP score—imaging before day 3 underestimates extent of necrosis 7
- Remember that even BISAP score of 1-2 does not guarantee benign course—one patient with BISAP of 1 died in the validation cohort 3